The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Cellular mechanisms of IL-17-induced blood-brain barrier disruption
Open accessAbstract
Recently T-helper 17 (Th17) cells were demonstrated to disrupt the blood-brain barrier (BBB) by the action of IL-17A. The aim of the present study was to examine the mechanisms that underlie IL-17A-induced BBB breakdown. Barrier integrity was analyzed in the murine brain endothelial cell line bEnd.3 by measuring the electrical resistance values using electrical call impedance sensing technology. Furthermore, in-cell Western blots, fluorescence imaging, and monocyte adhesion and transendothelial migration assays were performed. Experimental autoimmune encephalomyelitis (EAE) was induced in C57BL/6 mice. IL-17A induced NADPH oxidase- or xanthine oxidase-dependent reactive oxygen species (ROS) production. The resulting oxidative stress activated the endothelial contractile machinery, which was accompanied by a down-regulation of the tight junction molecule occludin. Blocking either ROS formation or myosin light chain phosphorylation or applying IL-17A-neutralizing antibodies prevented IL-17A-induced BBB disruption. Treatment of mice with EAE using ML-7, an inhibitor of the myosin light chain kinase, resulted in less BBB disruption at the spinal cord and less infiltration of lymphocytes via the BBB and subsequently reduced the clinical characteristics of EAE. These observations indicate that IL-17A accounts for a crucial step in the development of EAE by impairing the integrity of the BBB, involving augmented production of ROS.-Huppert, J., Closhen, D., Croxford, A., White, R., K…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“IL-17 impairs blood–brain barrier integrity, allowing for more immune cells to cross into the CNS [127,128].”
From The Role of Cortisol in Chronic Stress, Neurodegenerative Diseases, and Psychological Disorders (2023) · cites this paper as [127]
In the citing paper
“In turn, IL-17 further impairs BBB integrity, thus allowing more immune cells and cytokines to gain easy access to the CNS [65, 66].”
From Chronic stress-induced depression requires the recruitment of peripheral Th17 cells into the brain (2022) · cites this paper as [65]
Citations
Cites
Noseworthy, J. H., Lucchinetti, C., Rodriguez, M., & Weinshenker, B. G. (2000) · New England Journal of Medicine · doi:10.1056/nejm200009283431307 · Cited by 2,899
Kebir, H., Kreymborg, K., Ifergan, I., Dodelet-Devillers, A., Cayrol, R., Bernard, M., Giuliani, F., Arbour, N., Becher, B., & Prat, A. (2007) · Nature Medicine · doi:10.1038/nm1651 · Cited by 1,759 · cited 4×
“Recently, it was shown that both IL-17A and IL-22 can disturb BBB integrity, but the exact mechanism by which this occurs is not clear (5).”
BackgroundInfluentialSelf-citationMultiple Sclerosis — The Plaque and Its Pathogenesis
Frohman, E. M., Racke, M. K., & Raine, C. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052130 · Cited by 1,740 · cited 1×
“Multiple sclerosis (MS) is an autoimmune inflammatory disease of the CNS that is characterized by sclerotic lesions found throughout the brain white matter (1).”
BackgroundIL-23 is essential for T cell–mediated colitis and promotes inflammation via IL-17 and IL-6
Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., Mckenzie, B., Kleinschek, M. A., Owyang, A., Mattson, J., Blumenschein, W., et al. (2006) · Journal of Clinical Investigation · doi:10.1172/jci21404 · Cited by 1,542
IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis
Komiyama, Y., Nakae, S., Matsuki, T., Nambu, A., Ishigame, H., Kakuta, S., Sudo, K., & Iwakura, Y. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.1.566 · Cited by 1,536
TH-17 cells in the circle of immunity and autoimmunity
Bettelli, E., Oukka, M., & Kuchroo, V. K. (2007) · Nature Immunology · doi:10.1038/ni0407-345 · Cited by 1,517 · cited 1×
“A correlative link between IL-17A expression and the development of EAE has been well documented, as Th17 cells are abundant in the CNS of mice before and during the peak of the disease ( 35 ).”
BackgroundTzartos, J. S., Friese, M. A., Craner, M. J., Palace, J., Newcombe, J., Esiri, M. M., & Fugger, L. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070690 · Cited by 1,187 · cited 1×
“Th17 cells, which produce the cytokines IL-17A, IL-17F, and IL-22, were shown to infiltrate the CNS in patients with MS and in mice with EAE (23, 24).”
BackgroundAn essential role for free radicals and derived species in signal transduction
Lander, H. M. (1997) · The FASEB Journal · doi:10.1096/fasebj.11.2.9039953 · Cited by 902 · cited 1×
“We and others have demonstrated previously that ROS-induced activation of the endothelial contractile machinery leads to BBB disruption (14, 16, 26, 27, 36).”
BackgroundGarcia, J. G. N., Liu, F., Verin, A. D., Birukova, A., Dechert, M. A., Gerthoffer, W. T., Bamberg, J. R., & English, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12450 · Cited by 886 · cited 1×
“The endothelial contractile machinery is strongly regulated by the phosphorylation of myosin light chains (MLCs) ( 28 ).”
BackgroundRouvier, E., Luciani, M. F., Mattéi, M. G., Denizot, F., & Golstein, P. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.150.12.5445 · Cited by 775
Research works printed but not linked: 1
- 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q · DOI
Cited by
Items 301–400 of 528
Borovčanin, M., Janicijevic, S. M., Mijailović, N. R., Jovanović, I., Arsenijević, N., & Vesić, K. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.822579 · Cited by 17
“Interleukin-17 can induce blood-brain barrier disruption via a mechanism that depends on the production of reactive oxygen species, suggesting that IL-17 could exacerbate neurodegeneration through oxidative damage to lipids, proteins, and deoxyribonucleic acid (41).”
BackgroundPlasma sCD28, sCTLA-4 levels in neuromyelitis optica and multiple sclerosis during relapse
Wang, H., Wang, K., Zhong, X., Dai, Y., Wu, A., Li, Y., & Hu, X. (2011) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2011.11.010 · Cited by 17
“Auto-reactive T cells can migrate across the blood– brain barrier (BBB) and mediate damage against the myelin sheaths (Kebir et al., 2007; Huppert et al., 2010).”
BackgroundZhang, X., Kiapour, N., Kapoor, S., Merrill, J. R., Xia, Y., Ban, W., Cohen, S. M., Midkiff, B. R., Jewells, V. L., Shih, Y. I., et al. (2018) · Clinical Immunology · doi:10.1016/j.clim.2018.08.006 · Cited by 17
“Moreover, an IL-17A knockout mouse is resistant to EAE [25], and treatment of RRMS patients with an anti-IL-17 monoclonal antibody has shown therapeutic effects in a Phase II clinical trial [26].”
BackgroundAmmonia and beyond – biomarkers of hepatic encephalopathy
Gallego, J., Ballester, M. P., Fiorillo, A., Casanova‐Ferrer, F., López‐Gramaje, A., Urios, A., Arenas, Y. M., Ríos, M.-P., Durbán, L., Megías, J., et al. (2025) · Metabolic Brain Disease · doi:10.1007/s11011-024-01512-7 · Cited by 23
“This increased permeability allows the infiltration of immune cells and inflammatory factors into the central nervous system (Kebir et al. 2007; Reboldi et al. 2009 ; Huppert et al. 2010 ; Rochfort et al. 2014).”
Borgonetti, V., & Galeotti, N. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03236-8 · Cited by 16
Interleukins in Epilepsy: Friend or Foe
Dong, Y., Zhang, X., & Wang, Y. (2024) · Neuroscience Bulletin · doi:10.1007/s12264-023-01170-2 · Cited by 20
Braun, D. J., Bachstetter, A. D., Sudduth, T. L., Wilcock, D. M., Watterson, D. M., & Eldik, L. J. V. (2019) · GeroScience · doi:10.1007/s11357-019-00072-4 · Cited by 18
Expression of the interleukin 17 in cortical tubers of the tuberous sclerosis complex
He, J., Wu, K., Li, S., Shu, H., Zhang, C., Liu, S., Yang, M., Yin, Q., & Yang, H. (2013) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2013.05.007 · Cited by 17
CXCL10 and blood-brain barrier modulation in rabies virus infection
Gnanadurai, C. W., & Fu, Z. F. (2016) · Oncotarget · doi:10.18632/oncotarget.7428 · Cited by 16
Shukla, M., Garg, A., Dhole, T. N., & Chaturvedi, R. (2023) · Virology Journal · doi:10.1186/s12985-023-01966-8 · Cited by 15
Immunological characterization of an Italian PANDAS cohort
Leonardi, L., Lorenzetti, G., Carsetti, R., Mortari, E. P., Guido, C. A., Zicari, A. M., Förster‐Waldl, E., Loffredo, L., Duse, M., & Spalice, A. (2024) · Frontiers in Pediatrics · doi:10.3389/fped.2023.1216282 · Cited by 18
Tang, L., Bi, G., Lin, K., Chen, Y., Xian, H., Li, Y., Xie, H., Zheng, G., Wang, P., Chen, Y., et al. (2025) · Psoriasis Targets and Therapy · doi:10.2147/ptt.s535900 · Cited by 17
“39 Other kerati-nocyte-derived cytokines, such as IL-1β, IL-6, and TNF-α, can cross the BBB. 42 Aligning with the above pathological alterations, current research indicates that psoriasis-related psychological stresses (such as appearance anxiety, self-abasement) exactly promote the onset of…”
Zhang, L., Xu, R., Huang, H., Yang, J., Yu, C., Zhang, H., & Xu, Z. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1650909 · Cited by 15
Reis, M. F., Nascimento, J. V. P., de Carvalho, L. I., de Carvalho, D. C., Tironi, T. D. S., & Perobelli, S. M. (2022) · Revista Educação e Saúde fundamentos e desafios · doi:10.29327/2192205.2.3-8 · Cited by 14
Role of Regulatory T Cells in Intracerebral Hemorrhage
Shang, Y., Zheng, L., Du, Y., Shang, T., Liu, X., & Zou, W. (2024) · Molecular Neurobiology · doi:10.1007/s12035-024-04281-7 · Cited by 14
Chen, D., Zhang, Y., Yao, C., Li, B., Li, S., Liu, W., Chen, R., & Shi, F. (2021) · Allergy Asthma and Clinical Immunology · doi:10.1186/s13223-021-00568-9 · Cited by 14
Li, H., Jin, J., Yang, C., Wang, P., Huang, F., Wu, H., Zhang, B., Shi, H., & Wu, X. (2018) · RSC Advances · doi:10.1039/c7ra10246a · Cited by 15
Dias, A. T., de Castro, S. B. R., Alves, C. C. D. S., Mesquita, F. P., de Figueiredo, N. S. V., Evangelista, M. G., Castañon, M. C. M. N., Juliano, M. A., & Ferreira, A. P. (2015) · Cellular Immunology · doi:10.1016/j.cellimm.2014.12.009 · Cited by 15
“brain, and IFN-c has been shown to be more strongly associated with the onset and the peak of disease [48–50].”
Rossi, B., Dusi, S., Angelini, G., Bani, A., Lopez, N., Bianca, V. D., Pietronigro, E. C., Zenaro, E., Zocco, C., & Constantin, G. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1071553 · Cited by 13
Gravina, G., Ardalan, M., Chumak, T., Nilsson, A., Ek, J. C., Danielsson, H., Svedin, P., Pekny, M., Pekna, M., Sävman, K., et al. (2023) · iScience · doi:10.1016/j.isci.2023.107217 · Cited by 15
“Further, IL17 expression was associated with BBB disruption.(37,38) Similarly, CCL3 and CCL4 have been shown to contribute to demyelinating disease.”
BackgroundJha, M. K., Minhajuddin, A., Gadad, B. S., Fatt, C. C., & Trivedi, M. H. (2019) · Pharmaceuticals · doi:10.3390/ph12040184 · Cited by 13
“Reduced BBB integrity may be a putative mechanistic link between peripheral inflammation and CNS effects as previous reports suggest that pro-inflammatory cytokines in peripheral circulation bind to the endothelial cells of BBB and result in formation of reactive oxygen species [22].”
BackgroundUpdate on the role of T cells in cognitive impairment
Ruiz‐Fernández, I., Sánchez‐Díaz, R., Ortega‐Sollero, E., & Martín, P. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16214 · Cited by 17
“Additionally, the number of T-cell immunoglobulin and mucin-domain containing-3 ( TIM-3 ), mediated by a Th1 response, increases, along with TNF-α , leading to a heightened inflammatory response (Dolati et al., 2018; Huppert et al., 2010; Zhao et al., 2011).”
BackgroundYu, Y., Weiss, R. M., & Wei, S. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.1032434 · Cited by 13
Dai, H.-Y., Zhang, Z.-X., Tan, C., Xian, X., Ji, D., Yang, J., Sun, J., & Yao, H. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28817 · Cited by 14
“In vivo and in vitro experiments show that Th17 cells can infiltrate into the brain [46,47], while IL-17A can destroy the blood – brain barrier (BBB) [48].”
BackgroundDu, J., Fang, L., Dong, K., & Zhou, Z. (2024) · Journal of Affective Disorders · doi:10.1016/j.jad.2024.10.050 · Cited by 12
Arenas, Y. M., Montoliu, C., Llansola, M., & Felipo, V. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03310-5 · Cited by 14
In vitro protective efficacy of Lithium chloride against Mycoplasma hyopneumoniae infection
Ishag, H. Z. A., Wu, Y., Liu, M., Xiong, Q., Feng, Z., Yang, R., & Shao, G. (2016) · Research in Veterinary Science · doi:10.1016/j.rvsc.2016.03.013 · Cited by 12
“Fluorescence was measured immediately at excitation 485 nm and emission of 535 nm using an infinite F200 TecanMicroplate Reader (Huppert et al., 2010), and the data were acquired using i-control software (Tecan Trading AG, Ma ̈nnedorf, Switzerland).”
Wang, Q., Zhong, Y., Chen, N., & Chen, J. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1078984 · Cited by 12
“Th17 cells can promote the production of ROS and act on endothelial cells to induce BBB injury, so as to make peripheral immune cells and cytokines enter the brain parenchyma and promote brain inflammation, or IL-17 can directly play a neurotoxic role and lead to brain injury (Huppert et al., 2010; Waisman et al., 201…”
BackgroundŁaszczych, D., Czernicka, A., Gostomczyk, K., Szylberg, Ł., & Borowczak, J. (2024) · Medical Oncology · doi:10.1007/s12032-024-02434-1 · Cited by 12
“IL-17 can disrupt the integrity of the blood–brain barrier (BBB) through downregulation of occludin and activation of the endothelial contractile machinery [51].”
BackgroundLourda, M., Olsson‐Åkefeldt, S., Gavhed, D., Nygell, U. A., Berlin, G., Laurenčikas, E., Greenwood, T. V. B., Svensson, M., & Henter, J. (2016) · Blood · doi:10.1182/blood-2016-03-708107 · Cited by 12
The link between gut microbiota and multiple sclerosis from the perspective of barrier function
Ren, J., Niu, Z., Wang, J., Guo, J., Hao, H.-J., Gao, F., Liu, R., & Wang, Z. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1652796 · Cited by 15
“Paracellular translocation, often linked to the impairment of TJs, has been associated with direct damage to enterocytes and their supporting structures, along with signi fi cant changes in intestinal TJs gene expression and downregulation of both ZO-1 and occludin (210, 211).”
Fan, H., Yang, Y., Bai, Q., Wang, D., Shi, X., Zhang, L., & Yang, Y. (2023) · NeuroMolecular Medicine · doi:10.1007/s12017-023-08756-z · Cited by 11
“Moreover, the subsequent inflammatory response raises the BBB’s permeabil - ity even more and attracts additional immune cells to the CNS (Adamczyk-Sowa et al., 2016 ; McGinley et al., 2018 ; Michalickova et al., 2020 ; van den Hoogen et al., 2017 ).”
Yu, Y., Xue, B., Tong, L., Bassuk, A. G., Johnson, A. K., & Wei, S. (2025) · Journal of the American Heart Association · doi:10.1161/jaha.124.040461 · Cited by 13
“9–11 More recently, we reported that IL-17A prompts BBB disruption in the paraventricular nucleus (PVN) of the hypothalamus in a model of myocardial infarction-induced heart failure, by promoting caveolar transcytosis and degradation of tight junction complexes.”
From immunobiology to intervention: Pathophysiology of autoimmune encephalitis
Homeyer, M. A., Falck, A., Li, L. Y., & Prüß, H. (2025) · Seminars in Immunology · doi:10.1016/j.smim.2025.101955 · Cited by 15
CD4+ T cells in ischemic stroke: effects and therapeutic targets
Lian, Z., Luo, Y., Li, Y., Gao, Y., Xiong, X., & Gu, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1512634 · Cited by 14
Wu, Q. J., Mi, Y., Cheng, W., Xia, C., Zhu, D., & Du, D. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.121 · Cited by 11
T cell transgressions: Tales of T cell form and function in diverse disease states
Harris, K. M., Clements, M. A., Kwilasz, A. J., & Watkins, L. R. (2021) · International Reviews of Immunology · doi:10.1080/08830185.2021.1921764 · Cited by 12
“Increased ROS levels cause BBB endothelial cells to contract, leading to a reorganization and reduced expression of TJ proteins, such as occludin and zonula occludens-1, and ultimately BBB disruption [261,264].”
BackgroundSerum molecular biomarkers in neuromyelitis optica and multiple sclerosis
Fu, C., Gao, C., Zhang, H., Mao, Y., Lu, J.-Q., Petritis, B. O., Huang, A., Yang, X., Long, Y., & Huang, R. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.103527 · Cited by 12
Shafiei, M., & Mozhgani, S. (2023) · Molecular Neurobiology · doi:10.1007/s12035-023-03303-0 · Cited by 13
“Classical Th17 cells are also able to impair BBB via IL-17 production [133].”
BackgroundPark, H., Pagan, L., Tan, O., Fadiel, A., Demır, N., Huang, K., Mittal, K., & Naftolin, F. N. (2010) · Reproductive Sciences · doi:10.1177/1933719110379649 · Cited by 11
“A decreased NCAM: PSA-nCAM ratio is accompanied by failure of cell: cell adhesion that precedes the departure of leucocytes from the circulation.(29) The transvascular passage of leukocytes is known to be important in the development of vascular inflammation and atheromas.”
BackgroundImmune Responses to Non-Tumor Antigens in the Central Nervous System
Huber, A. K., Duncker, P. C., & Irani, D. N. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00328 · Cited by 11
“Finally, IL-17 can disrupt TJ in the BBB, allowing further migration of CD4+ T cells to the CNS (212, 215).”
BackgroundCurcumin Impact on Multiple Sclerosis
Qureshi, M., Al-Suhaimi, E. A., & Shehzad, A. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815461-8.00020-7 · Cited by 13
CARE-NS, a research strategy for neurosyphilis
Du, F., Zhang, X., Zhang, R., & Wang, Q. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1040133 · Cited by 12
“For example, the cytokine IL-17 compromises the connection between tight junction occludins and activates endothelial contraction to increase BBB permeability (28).”
BackgroundTransient High Salt Intake Promotes T-Cell–Mediated Hypertensive Vascular Injury
Yakoub, M., Rahman, M., Kleimann, P., Hoffe, J., Feige, M., Bouvain, P., Alter, C., Kluczny, J. I., Reidel, S., Nederlof, R., et al. (2024) · Hypertension · doi:10.1161/hypertensionaha.124.23115 · Cited by 11
Zhang, J., Zhou, F., Roberts, N., Yuan, Q., Wang, M., Wu, G., Yang, W., Fu, P., Wang, M., & Hu, J. (2024) · International Journal of Surgery · doi:10.1097/js9.0000000000002173 · Cited by 12
El-Taibany, A. A., Heydarian, P., Porada, D. A., Seeds, M. C., & Atala, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1595276 · Cited by 12
Crockett, A. M., Colόn, M. C. V., Kébir, H., Smith, F. M., Iascone, D. M., Ciesielski, B., Кошкин, С. А., Patterson, A. D., Rossano, A. J., Sehgal, A., et al. (2025) · Science Translational Medicine · doi:10.1126/scitranslmed.ads2116 · Cited by 11
Is there a window of opportunity for the therapeutic use of vitamin D in multiple sclerosis?
Sartori, A., Zorzella-Pezavento, S. F. G., Mimura, L. A. N., Denadai, M., de Souza, W. D. F., & Fraga‐Silva, T. F. D. C. (2022) · Neural Regeneration Research · doi:10.4103/1673-5374.335139 · Cited by 11
“These authors also reported that oral treatment with 14,007 IU/d cholecalciferol for 48 weeks protected the patients against the development of new MRI lesions (Hupperts et al., 2019).”
BackgroundMethodGateway reflexes: A new paradigm of neuroimmune interactions
Ohki, T., Kamimura, D., Arima, Y., & Murakami, M. (2017) · Clinical and Experimental Neuroimmunology · doi:10.1111/cen3.12378 · Cited by 11
Zhong, J., Yau, A. C. Y., & Holmdahl, R. (2020) · Journal of Neuroinflammation · doi:10.1186/s12974-020-01789-2 · Cited by 12
JAK-STAT Lodges in Multiple Sclerosis: Pathophysiology and Therapeutic Approach Overview
Hamid, K. M., Isiyaku, A., Kalgo, M. U., Yahaya, I. S., & Mirshafiey, A. (2017) · OALib · doi:10.4236/oalib.1103492 · Cited by 11
“High levels of IL-17 in MS lesion are associated with strong inflammatory response which could lead to exacerbations of the disease [70].”
BackgroundWu, Q., Zhou, Y., Yan, J., Li, X. J., Meng, F., Wang, B., & Yin, L. (2024) · Nano Today · doi:10.1016/j.nantod.2024.102444 · Cited by 9
Foiadelli, T., Loddo, N., Sacchi, L., Santi, V., Giulia, D., Spreafico, E., Orsini, A. A., Ferretti, A., Amici, M. D., Giorgia, T., et al. (2024) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2024.11.004 · Cited by 9
Attenuation of relapsing fever neuroborreliosis in mice by IL-17A blockade
Cheng, M., Xu, J., Ding, K., Zhang, J., Lu, W., Liu, J., Gao, J., Alugupalli, K. R., & Liu, H. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2205460119 · Cited by 12
“IL-17 can activate microglia and astrocytes to produce inflammatory cytokines and chemokines that can recruit inflammatory cells from the periphery into the CNS thereby exacerbating CNS manifestations (25).”
BackgroundAhuja, M., Patel, M., Majrashi, M., Mulabagal, V., & Dhanasekaran, M. (2017) · Medicinal and aromatic plants of the world · doi:10.1007/978-981-10-5978-0_1 · Cited by 12
Afshar, B., Ganjalıkhani-Hakemi, M., Khalifehzadeh-Esfahani, Z., Eskandari, N., Shaygannajad, V., Hosseininasab, F., & Alsahebfosoul, F. (2021) · Basic and Clinical Neuroscience Journal · doi:10.32598/bcn.2021.2252.1 · Cited by 9
“These cells appear to be correlated with the progression of CNS autoimmune diseases (Huppert et al., 2010; Ponomarev et al., 2007).”
BackgroundThe role of interleukin-17 in epilepsy
An, J., Li, H., Xia, D., Xu, B., Wang, J., Qiu, H., & He, J. (2022) · Epilepsy Research · doi:10.1016/j.eplepsyres.2022.107001 · Cited by 10
Li, J., Liao, W., Huang, Z.-M., Yin, X., Ouyang, S., Gu, B., & Guo, X. (2023) · European journal of medical research · doi:10.1186/s40001-022-00980-w · Cited by 9
“Huppert, Jula et al. disclosed that IL-17 is involved in the disruption of the BBB [35], which is frequently fatal and related to long-term neurological sequelae [36].”
BackgroundShuttleworth, S., Townsend, P. A., Silva, F., Cecil, A., Hill, T., Tomassi, C., Rogers, H., & Harrison, R. (2011) · Progress in medicinal chemistry · doi:10.1016/b978-0-12-381290-2.00003-3 · Cited by 11
Marín, N., Eixarch, H., Mansilla, M. J., Rodríguez‐Martín, E., Mecha, M., Guaza, C., Alvarez-Cermeño, J. C., Montalbán, X., Villar, L. M., & Espejo, C. (2013) · Clinical & Experimental Immunology · doi:10.1111/cei.12233 · Cited by 9
A possible role for IL-17 in Clarkson's disease
Simonin, M., Corbeau, P., Durand, P., Rosenzwajg, M., Filleron, A., & Tran, T.-A. (2016) · European Journal of Paediatric Neurology · doi:10.1016/j.ejpn.2016.08.003 · Cited by 9
Long, T., Zhang, B., Fan, R., Wu, Y., Mo, M., Luo, J., Chang, Y., Qin, T., Mei, M., Jiang, H., et al. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.00109 · Cited by 9
Ullah, A., Singla, R. K., Zhang, Y., Hu, S., & Shen, B. (2025) · Journal of Pharmaceutical Analysis · doi:10.1016/j.jpha.2025.101249 · Cited by 8
“Myosin light chain kinase (MLCK) activation results in the downregulation of occludin [38].”
Zhang, M., Hong, Y., Yu, W., Zhang, Y., Shen, Y., Cai, Z., Jia, R., Pang, Z., Huang, X., Huang, Y., et al. (2025) · International Immunopharmacology · doi:10.1016/j.intimp.2025.114513 · Cited by 8
New directions of immunocorrection in multiple sclerosis
Boyko, A. N., Хачанова, Н. В., Melnikov, M., Sivertseva, S. A., Evdoshenko, E., Спирин, Н. Н., Vasilyev, A. V., & Rozenson, O. (2020) · S S Korsakov Journal of Neurology and Psychiatry · doi:10.17116/jnevro2020120021103 · Cited by 8
CCL21 contributes to Th17 cell migration in neuroinflammation in obese mice following lead exposure
Wang, W., Liu, E., Li, X., Chen, S., Pang, S., & Zhang, Y. (2022) · Toxicology Letters · doi:10.1016/j.toxlet.2022.06.003 · Cited by 8
Dissecting the immune response of CD4+ T cells in Alzheimer’s disease
Kostić, M. S., Živković, N., Cvetanović, A., Bašić, J., & Stojanović, I. R. (2024) · Reviews in the Neurosciences · doi:10.1515/revneuro-2024-0090 · Cited by 8
Smith, S., Smith, J., Jones, K., Castillo, A., Wiemann, N., Howard, A., & Cunningham, M. (2025) · Hypertension in Pregnancy · doi:10.1080/10641955.2025.2454597 · Cited by 11
“Reactive astrocytes, associated with an increased GFAP expression and inflammatory cytokine production, can be present in HTN, and other CVDs, such as stroke and dementia (58,66).”
InfluentialEvangelista, M. G., de Castro, S. B. R., Alves, C. C. D. S., Dias, A. T., Souza, V. W. D., dos Reis, L. B., da Silva, L. C., Castañon, M. C. M. N., Farias, R. E., Juliano, M. A., et al. (2016) · Autoimmunity · doi:10.3109/08916934.2016.1141898 · Cited by 9
“IL-17-producing Th17 cells act via formation of reactive oxygen species that down-regulate tight junction proteins and stimulate the endothelial contractile machinery [43].”
BackgroundAlizadeh, H., Daryanoosh, F., Moatari, M., & Hoseinzadeh, K. (2015) · PubMed Central · Cited by 12
New and emerging immune‐targeted drugs for the treatment of multiple sclerosis
Palmer, A. M. (2013) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.12285 · Cited by 12
Glenn, J. D., Xue, P., & Whartenby, K. A. (2017) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2017.12.002 · Cited by 10
“…via reactive oxygen species to allow CNS entry, induce inflammatory gene expression in astrocytes, produce chemo-attractive molecules targeting neutrophils and monocytes, and enhance peripheral TH17 migration (Huppert et al., 2010; Kebir et al., 2007; Reboldi et al., 2009; Zhu and Qian, 2012).”
BackgroundThe Role of Th17 Cells in Immunopathogenesis of Neuroinflammatory Disorders
Pourgholaminejad, A., & Tahmasebinia, F. (2019) · Contemporary clinical neuroscience · doi:10.1007/978-3-030-19515-1_3 · Cited by 9
Multiple sclerosis and oxidative stress—a clinical perspective
Kostić, M. S., Rajković, J., Floranović, M. P., Dimov, I., & Pavlovic, D. D. (2013) · Neurochemical Journal · doi:10.1134/s1819712412040083 · Cited by 9
Regulatory T cells in stroke inflammation: Therapeutic perspectives
Sun, Z., Zhou, H., Wang, Y., & Li, Z. (2025) · Neural Regeneration Research · doi:10.4103/nrr.nrr-d-24-01424 · Cited by 7
“Upon activation, it stimulates the production of reactive oxygen species and reduces the expression of tight junction proteins, leading to BBB compromise (Huppert et al., 2010).”
The role of neuroinflammation in schizophrenia: Focus on Th17 cells functions
Melnikov, M., Lopatina, A., Sviridova, A., Chugunov, A. V., Vavilis, T., Stamatellos, V., Stamoula, Ε., & Cosentino, M. (2025) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2025.104629 · Cited by 8
Jiang, Y., Liu, Z., Hu, J., Sun, S., Xie, X., Kong, X., & Tang, Y. (2023) · Journal of Traditional Chinese Medical Sciences · doi:10.1016/j.jtcms.2023.03.007 · Cited by 9
Li, J., Yang, R., Wang, S., Shen, Z., Wu, B., Ren, Y., K, S. S., & Jiang, G. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15849 · Cited by 7
Li, F., Liu, P., Guo, Y., Han, Z.-L., Liu, Y., Wang, Y., Song, L., Cheng, J., & Chen, Z. (2018) · Archives of Virology · doi:10.1007/s00705-018-3807-9 · Cited by 7
“1 3 the endothelial contractile machinery [40].”
Bell, M. B., Ouyang, X., Shelton, A., Huynh, N. V., Mueller, T., Chacko, B. K., Jegga, A. G., Chatham, J. C., Miller, C. R., Darley-Usmar, V. M., et al. (2023) · Journal of Neurochemistry · doi:10.1111/jnc.15835 · Cited by 7
Pro-Inflammatory Phenotype Induced by Maternal Immune Stimulation During Pregnancy
Nicholas, M., Mandal, M., Elkabes, S., Zhang, P., Sadoshima, J., Basak, S., Zhai, P., & DONNELLY, R. J. (2013) · InTech eBooks · doi:10.5772/53990 · Cited by 9
“Encephalomyelitis (EAE), a mouse model of multiple sclerosis [122-128].”
BackgroundRegulatory Lymphocytes Are Key Factors in MHC-Independent Resistance to EAE
Marín, N., Mecha, M., Espejo, C., Mestre, L., Eixarch, H., Montalbán, X., Alvarez-Cermeño, J. C., Guaza, C., & Villar, L. M. (2014) · Journal of Immunology Research · doi:10.1155/2014/156380 · Cited by 7
Interleukin-17A Contributed to the Damage of Blood-CNS Barriers During Streptococcus suis Meningitis
Xu, L., Lü, X., Xiao, P., Liu, R., Xia, K., Wu, M., Jin, M., & Zhang, A. (2022) · Molecular Neurobiology · doi:10.1007/s12035-022-02749-y · Cited by 7
The immune-microbiome axis in salt-sensitive hypertension: a focus on renal and neural mechanisms
Cardoso, L. M., & Wainford, R. D. (2025) · Frontiers in Physiology · doi:10.3389/fphys.2025.1653387 · Cited by 6
“Blocking either ROS formation or myosin light chain phosphorylation or sequestering IL-17 with IL‐17A‐neutralizing antibodies prevented IL‐17A‐induced BBB disruption (Huppert et al., 2010).”
Pharmacotherapeuetic Options for the Treatment of Multiple Sclerosis
Palmer, A. M. (2012) · Clinical Medicine Insights Therapeutics · doi:10.4137/cmt.s8661 · Cited by 9
919 granules improve postpartum depression through the regulation of abnormal peripheral blood IL-1β
Wang, S., Zhao, Y., Yang, Z., Liu, Y., Xu, R., Tu, R., Liu, S., Zou, X., Zhang, L., Hao, J., et al. (2024) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2024.116623 · Cited by 8
Interactions between Cytokines and the Pathogenesis of Prion Diseases: Insights and Implications
Lemos, G. G. M., Moura-do-Nascimento, R., Amaral-do-Nascimento, M., Miceli, A. C., & Vieira, T. C. R. G. (2024) · Brain Sciences · doi:10.3390/brainsci14050413 · Cited by 8
“Pro-inflammatory cytokines exert multifaceted effects on the cerebrovascular system, precipitating Notably, these cytokines can induce (i) downregulation of integral tight junction proteins such as claudin and occludin [29,58,64,65,70].”
BackgroundInfluentialAhmad, F., Ahmad, S., Husain, A., Pandey, N., Khubaib, M., & Sharma, R. (2024) · Journal of NeuroVirology · doi:10.1007/s13365-024-01212-z · Cited by 6
“It produced these pro-inflammatory cytokines from activated microglial cells, astrocyte endothelial cells at the site of infection or injury in the brain (Huppert et al. 2010;Chen et al. 2014; Chen et al. 2012; Kim et al. 2016a, b).”
Beard, R. S., Hoettels, B. A., McAllister, J. M., Meegan, J. E., Wertz, T. S., Self, D. A., Hrkach, D. E., Greiner, D., Chapman, K., Villalba, N., et al. (2025) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1177/0271678x251318620 · Cited by 6
“69 This was accompanied by myelin sparing in the cerebellum based on MBP (Figure 1(f)).”
Mokarizadeh, A., Abdollahi, M. R., Rezvanfar, M. A., & Rahmani, M. R. (2013) · Journal of Medical Hypotheses and Ideas · doi:10.1016/j.jmhi.2013.11.002 · Cited by 6
“9 (IFN-γ), interleukin-17 (IL-17) and nitric oxide (NO) and expansion of myelinspecific antibodies (Th2 response) [29, 50-52].”
BackgroundAi, X., Huang, H., Miao, Z., Zhou, T. Y., Wu, H., & Lai, Y. R. (2021) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2021.104991 · Cited by 6
Fan, D., Gu, Y.-T., Lv, H., Tang, T., Xu, Z.-H., Song, Z., & Xiao-jie, T. (2011) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-011-9723-0 · Cited by 6
“Oxidative stress may disturb the function of BBB after SBI ( Huppert et al. 2010 ), and the injury may also trigger the inflammatory cells to active and migrate into the brain tissues.”
BackgroundMokarizadeh, A., Esmaeili, P., Soraya, H., Hassanzadeh, K., Jalili, A., Abdi, M., & Faryabi, M. R. (2015) · Journal of Medical Hypotheses and Ideas · doi:10.1016/j.jmhi.2015.02.002 · Cited by 6
Targeting Inflammatory T Cells in Multiple Sclerosis: Current Therapies and Future Challenges
Tuosto, L. (2015) · Austin Journal of Multiple Sclerosis & Neuroimmunology · doi:10.26420/austinjmultsclerneuroimmunol.2015.1009 · Cited by 7
“The hallmark of Th17 cells is the production of the proinflammatory cytokine IL-17 (A and F) that affects the functions of a wide range of cells, enhances the secretion of other pro-inflammatory cytokines and chemokines and increases the activation of matrix metalloproteinases, thus contributing to the breakdown of BB…”
BackgroundInfluentialWayne, C. R., Bremner, L., Faust, T. E., Durán‐Laforet, V., Ampatey, N., Ho, S. J., Feinberg, P. A., Arvanitis, P., Ćirić, B., Ruan, C., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.03.10.532135 · Cited by 7
Cui, Z., Yang, Q., Yang, F., Yang, Y., Yang, X., Yu, Y., Cai, Y., Fan, X., & Bai, R. (2025) · Biomedicines · doi:10.3390/biomedicines13112838 · Cited by 6
“Inflammation compromises the integrity of the blood–brain barrier (BBB) by upregulating matrix metalloproteinases (MMPs), damaging the vascular endothelium, and increasing cellular permeability [120,121].”
Li, Z., Qin, P., Sun, Z., Li, L., Liang, P., Zhao, Y., Ren, S., Wang, G., & Yang, J. (2026) · Communications Biology · doi:10.1038/s42003-026-09525-x · Cited by 5
“…nervous system (CNS) during early CRS exposure 60 , and IL-17 has been shown to disrupt the blood-brain barrier (BBB), facilitating the in fi ltration of immune cells and cytokines into the CNS, thereby exacerbating depressive symptoms 61,62 .”
Ranjbary, A. G., Mehrzad, J., Dehghani, H., & Hosseinkhani, S. (2025) · Archives of Medical Research · doi:10.1016/j.arcmed.2025.103220 · Cited by 5
Cinnamomum cassia Alleviates Neuropsychiatric Lupus in a Murine Experimental Model
Maalouly, G., Saliba, Y., Hajal, J., Zein-El-Din, A., Fakhoury, L., Najem, R., Smayra, V., Nassereddine, H., & Farès, N. (2025) · Nutrients · doi:10.3390/nu17111820 · Cited by 5
“This is in contrast to other authors’ results [32] demonstrating that IL-17 disrupts the BBB and results in a decreased expression of occludin and ZO-1.”
Immunomodulatory medicines for multiple sclerosis: Progress and prospects
Palmer, A. M. (2011) · Drug Development Research · doi:10.1002/ddr.20476 · Cited by 5
“IL-17 and -22 disrupt the BCNSB, which permits the movement of Th17 cells into the CNS parenchyma where they contribute to neurodegenerative changes [Kebir et al., 2007; Huppert et al., 2010].”
Background
Metadata
- Authors
- Huppert, J., Closhen, D., Croxford, A., White, R., Kulig, P., Pietrowski, E., Bechmann, I., Becher, B., Luhmann, H. J., Waisman, A., & Kuhlmann, C. R. W.
- Affiliations
- Johannes Gutenberg University Mainz (DE)
- University of Zurich (CH)
- Leipzig University (DE)
- Corresponding author
- Waisman, Ari
- Kuhlmann, Christoph R. W.
- Venue
- The FASEB Journal
- Publisher
- Wiley
- Published
- 2009-11-25
- Volume
- 24
- Issue
- 4
- Pages
- 1023-1034
- ISSN
- 0892-6638 (ISSN-L)
- 1530-6860
- OpenAlex
- W2071205488
- Semantic Scholar
- 28487cafa06774aea634538871f39aa337f374e1
- Cited by
- 529
- References
- 41
- Citations by year
- 2026: 29 · 2025: 41 · 2024: 43 · 2023: 40 · 2022: 43 · 2021: 44 · 2020: 21 · 2019: 21 · 2018: 31 · 2017: 28 · 2016: 32 · 2015: 31 · 2014: 27 · 2013: 35 · 2012: 15
- FWCI
- 13.42
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Locations
- The FASEB Journal (publishedVersion)
- PubMed (publishedVersion)
- Zurich Open Repository and Archive (University of Zurich) (acceptedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich)
- Funders
- Deutsche Forschungsgemeinschaft (SFB TR52/C2)
- Boehringer Ingelheim Stiftung
- Topics
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
- Health Sciences › Medicine › Immunology and Allergy › Cell Adhesion Molecules Research
- Keywords
- IL-17A, blood-brain barrier disruption, Th17 cells, experimental autoimmune encephalomyelitis, reactive oxygen species, NADPH oxidase, xanthine oxidase, oxidative stress, myosin light chain phosphorylation, myosin light chain kinase, ML-7, occludin, tight junctions, endothelial contractility, monocyte adhesion, lymphocyte transendothelial migration, bEnd.3 endothelial cells
- MeSH terms
- Animals, Azepines, Blood-Brain Barrier, Cell Line, Transformed, Encephalomyelitis, Autoimmune, Experimental, Enzyme Inhibitors, T-Lymphocytes, Helper-Inducer, Membrane Proteins, Mice, Inbred BALB C, Myosin-Light-Chain Kinase, Naphthalenes, Xanthine Oxidase, Down-Regulation, Reactive Oxygen Species, Oxidative Stress, NADPH Oxidases, Interleukin-17, Endothelial Cells, Mice, Antibodies, Neutralizing, Occludin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.